Given the function of intracellular BAG6 in many crucial biological processes such as protein targeting and degradation 17, we hypothesize that its anti-tumor activity relies on BAG6-dependent recruitment of other effector molecules to EVs. The gene discussed is BAG6; the disease is neoplasm.